Dy GK, Prasad D, Kumar P, Attwood K, et al. A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Nintedanib Versus Placebo as Prophylaxis Against Radiation Pneumonitis in Patients With Unresectable NSCLC Undergoing Chemoradiation Therapy. J Thorac Oncol 2021;16:e19-e20.
PMID: 33641724